Mechanism of valproic acid-induced hepatic steatosis via enhancing NRF2-FATP2-mediated fatty acid uptake
Theranostics · 2025
DOI: 10.7150/thno.108593 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, 2025. Verfasst von Xiaoliang He und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Valproic Acid, Fatty Liver, Fatty Acids. Die Arbeit wurde bisher 11-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
- State Key Laboratory of Traditional Chinese Medicine Syndrome, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
- Key Laboratory of Chronic Disease Prevention and Control of Traditional Chinese Medicine of Guangdong Higher Education Institutes, Guangzhou University of Chinese Medicine, KLGHEI (2024KSYS024), Guangzhou 510006, China.
Zitieren
APA
He, X., Yuan, R., Chen, Y., Huang, W., Xu, Z., Wang, B., Liu, C., & Xiong, T. (2025). Mechanism of valproic acid-induced hepatic steatosis via enhancing NRF2-FATP2-mediated fatty acid uptake. Theranostics. https://doi.org/10.7150/thno.108593
Vancouver
He X, Yuan R, Chen Y, Huang W, Xu Z, Wang B, et al. Mechanism of valproic acid-induced hepatic steatosis via enhancing NRF2-FATP2-mediated fatty acid uptake. Theranostics. 2025. doi:10.7150/thno.108593
BibTeX
@article{He2025,
author = {He, Xiaoliang and Yuan, Rui and Chen, Ying and Huang, Wenni and Xu, Zihao and Wang, Bixia and Liu, Changhui and Xiong, Tianqin},
title = {Mechanism of valproic acid-induced hepatic steatosis via enhancing NRF2-FATP2-mediated fatty acid uptake},
journal = {Theranostics},
year = {2025},
doi = {10.7150/thno.108593}
}
EUVIMED